RECRUITINGOBSERVATIONAL
PEPPI Study: Identification of Women at Risk for Placental Dysfunction
PEPPI Study: Identification of Women at Risk for Placental Dysfunction During the First and Third Trimesters of Pregnancy
About This Trial
The main purpose of this study is to evaluate Fetal Medicine Foundation's pre-eclampsia risk calculator using maternal characteristics, first trimester serum placental growth factor (PlGF) and mean arterial pressure (MAP) in a Finnish general population. Condition or disease: pre-eclampsia, intrauterine growth restriction, polycystic ovary syndrome
Who May Be Eligible (Plain English)
Mothers
Inclusion Criteria for PEPPI-study
- Pregnant (first trimester)
- Understands Finnish
- ≥18 years
- Signed willing to sign a consent form
Exclusion Criteria
- Multiple pregnancy
- Miscarriage/termination of the index pregnancy
- No first trimester blood sampling
Inclusion Criteria for FERPPI-study
- Participates in PEPPI-study (criteria above)
- Blood samples at first and third trimester of pregnancy
- Permits blood sampling from the umbilical cord when the baby is born
Exclusion Criteria
- No first or third trimester blood sampling
- No umbilical cord blood sample after baby is born
Fathers
Inclusion Criteria
- Biological father to the child born for the mother who participated in PEPPI study
- ≥18 years
- Signed willing to sign a consent form
Exclusion Criteria
• Does not understand Finnish
Children
Inclusion Criteria for PEPPI-study
- Born to mother who participated in PEPPI study
- Signed willing to sign a consent form from parent(s)
Exclusion Criteria
• No consent from parent(s)
Inclusion Criteria for PEPPI-offspring study • Mother in risk-, control-, or PCOS group during PEPPI-study with ultrasound information at gestational weeks 30-32 or a mother who developed pre-eclampsia during the pregnancy regardless of their study group during PEPPI-study
Exclusion Criteria
• Mother/father declines participation
Inclusion Criteria for FERPPI-study
- Signed willing to sign a consent form from parent(s)
- Mother has blood samples taken at first and third trimester (iron status)
- Child has blood samples taken at birth and at 3 months of age
Exclusion Criteria
- No consent from parent(s)
- No blood samples from mother
- No blood samples from child
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Mothers
Inclusion Criteria for PEPPI-study
* Pregnant (first trimester)
* Understands Finnish
* ≥18 years
* Signed informed consent
Exclusion Criteria
* Multiple pregnancy
* Miscarriage/termination of the index pregnancy
* No first trimester blood sampling
Inclusion Criteria for FERPPI-study
* Participates in PEPPI-study (criteria above)
* Blood samples at first and third trimester of pregnancy
* Permits blood sampling from the umbilical cord when the baby is born
Exclusion Criteria
* No first or third trimester blood sampling
* No umbilical cord blood sample after baby is born
Fathers
Inclusion Criteria
* Biological father to the child born for the mother who participated in PEPPI study
* ≥18 years
* Signed informed consent
Exclusion Criteria
• Does not understand Finnish
Children
Inclusion Criteria for PEPPI-study
* Born to mother who participated in PEPPI study
* Signed informed consent from parent(s)
Exclusion Criteria
• No consent from parent(s)
Inclusion Criteria for PEPPI-offspring study • Mother in risk-, control-, or PCOS group during PEPPI-study with ultrasound information at gestational weeks 30-32 or a mother who developed pre-eclampsia during the pregnancy regardless of their study group during PEPPI-study
Exclusion Criteria
• Mother/father declines participation
Inclusion Criteria for FERPPI-study
* Signed informed consent from parent(s)
* Mother has blood samples taken at first and third trimester (iron status)
* Child has blood samples taken at birth and at 3 months of age
Exclusion Criteria
* No consent from parent(s)
* No blood samples from mother
* No blood samples from child
Treatments Being Tested
OTHER
Pre-eclampsia screening program
Pregnant women will be devided into risk-, control- and PCOS groups according to first trimester screening program.
Locations (1)
The Wellbeing Services County of North Ostrobothnia
Oulu, Finland